Improve Identification of Pregnant People at Risk
Introductory Paragraph
Drug, alcohol, and even tobacco use during pregnancy have lasting and sometimes detrimental effects on mothers and unborn babies. Prenatal use of substances can cause the infant to be born with very serious health problems, stillbirths, and in some cases can cause infant withdrawal symptoms, or dependency (1). Alcohol use during pregnancy can lead to what is known as Fetal Alcohol Syndrome (FAS), characterized by low birth weight, cognitive deficits, increased risk of birth defects, and behavioral problems later in life (1). In 2012, almost 6% of pregnant women used illicit substances, 15.9% endorsed using tobacco, and over 8% drank alcohol(2). This accounted for well over a quarter of a million infants exposed to illicit substances in utero, over half a million exposed to alcohol, and one million exposed to tobacco. The detrimental impact of prenatal substance use continues to be a public health concern.
Key Information
Primary Prevention The implementation of thorough screening and education in primary care settings for all females of reproductive age, not just those who are currently pregnant, could drastically impact the occurrence of prenatal substance use (5). Since about half of all pregnancies are unplanned, many women could be using alcohol or other substances without knowing they are pregnant. Physicians can provide broad education on the risks of using substances and the possibility of unknowingly becoming pregnant while continuing to use. Early detection and intervention for substance use in women of childbearing age can offer an opportunity for women to take necessary precautions such as contraception or abstaining from substance use if there is a chance of becoming pregnant. Medical providers and public health officials can increase education about the effects of substances and the associated risks. Women, in general, have unique risks pertaining to alcohol, tobacco, and illicit substance use when compared to males. For example, the National Center for Addiction and Substance Abuse (CASA) reports the following statistics for women when compared to men (5).
- Greater impairment after drinking the same amount of alcohol;
- Accelerated development of alcohol-related problems;
- Greater susceptibility to the development of alcohol-related medical disorders;
- Increased asthma attacks;
- Becoming addicted to nicotine at lower levels of use;
- Greater impairment of lung functioning;
- Greater difficulty quitting smoking;
- Greater susceptibility to brain damage from heavy use of Ecstasy;
- Greater likelihood of hospitalization from nonmedical use of pain medications;
- Moderate to heavy alcohol consumption increases risks for breast cancer;
- Increased risk of female infertility;
Along with all of these harmful impacts that substance use has on women in general, substance use also places women of reproductive age at a heightened risk for unplanned pregnancy. Medical provider training and improved local support for prevention in this area could potentially reduce the number of women who knowingly or unknowingly become pregnant and expose their unborn children to substances. Physicians can also screen and empower women who use substances to seek treatment or take precautions so as to not become pregnant through the use of contraceptives.
Screening, Brief Intervention, and Referral to Treatment (SBIRT)(6) Brief Screening consists of the provider asking a series of questions that can help to identify where patients fall under a continuum of substance use, not merely just “addicted” or “non-addicted”. SBIRT’s model of substance use has six categories that patients can fall under. The six categories are:
- abstinence
- experimental use
- social use
- binge use
- abuse
- substance use disorder.
The goal of SBIRT is to identify individuals who are unaware that their behaviors are putting them at risk for developing more serious issues. With feedback and support from medical providers, these individuals have the opportunity to make an informed decision and change their current behavior or seek treatment if needed. If a patient is deemed “moderate”, “high risk”, or “problematic use” the provider can provide a brief intervention and referral for treatment. SBIRT can be implemented with minimal time and effort on behalf of the provider. The impact SBIRT has on the patient is invaluable and helps connect patients who need education and referral to treatment.
Relevant Research
In this section, please capture any recent findings, reports, or data on the topic. Please also highlight any gaps or existing disparities. Please include references and links to the information so that we may add a footnote for the reader to find further information. Do we have any available research about discriminatory practices? Is there information about the value of access to educational opportunities?
Impactful Federal, State, and Local Policies
Please list any federal, state, or local laws, policies, or regulations that support this topic or ones that could be a possible barrier. Are there laws or policies other states should know about and replicate for success?
Available Tools and Resources
Oftentimes, there are already great resources in the field that have been developed, but they are not housed in a single place. Please use this section to share information about those resources and drive the reader to that resource. It may be a worksheet, toolkit, fact sheet, framework/model, infographic, new technology, etc. I suggest no more than 5 really good links and a corresponding description for the reader. We also can use this section to highlight some of the great resources and programs at SAFE Project.
TR-Creating Improve Identification of a Women At Risk of having NAS Baby
Promising Practices
Please link to any best practice models or case studies that highlight creative/innovative or successful efforts in support of this strategy. Is there a community that does a really good job in this area that other communities should replicate? Please write a brief description and provide a link.